Unlike unfractionated heparin (UFH), the low-molecular-weight heparin enoxaparin (Lovenox) is excreted mainly by the kidneys. To determine whether this characteristic heightens bleeding risk in ...

Uninsured people who paid out of pocket for the anticoagulant drug Lovenox may be eligible for a payment from a $120 million proposed settlement in a dispute between Nashville General Hospital and two ...

Rockville, MD - The FDA's MedWatch program and Aventis Pharmaceuticals have issued a reminder to physicians about the use of enoxaparin (Lovenox TM) in patients with renal impairment. According to ...

(Reuters) - The U.S. Food and Drug Administration issued a new warning on the use of the anticoagulant Lovenox in patients fitted with a spinal catheter because of the risk of spinal column bleeding ...

BRIDGEWATER, N.J., Feb. 7 (UPI) -- Sanofi-aventis said Wednesday the U.S. Food and Drug Administration granted its blood-thinner Lovenox priority review for acute heart attack. The company said it is ...

A California biotechnology company won Food and Drug Administration permission Monday to sell a generic version of the blockbuster blood thinner Lovenox, following a years-long battle that was ...

Well, we sort of figured this was coming. Sanofi-Aventis has gone to court here in Washington to prevent rival drugmaker Novartis from selling a generic version of the blockbuster blood-thinner ...

Yesterday a judge put off a ruling on Sanofi-Aventis's request to keep a generic version of its anti-clotting drug Lovenoxfrom hitting the market, saying he needed more time to review the details of ...

PARIS, Feb 9 (Reuters) - French drugs group Sanofi-Aventis said on Friday a California court had ruled against it in a case pitting it against Amphastar and Teva over the best-selling Lovenox drug.